Company intelligence / Profile preview

Scarlett Pharma

Bristol, United Kingdom

Ownership: Private
Development stage: Other

Overview

Scarlet has developed a proprietary platform generating therapeutic red blood cells containing high levels of therapeutic proteins. The technology has been validated in peer-reviewed studies demonstrating lab-grown red blood cell production and protein loading capabilities.[1][2]

Therapeutic areas: OncologyNephrologyImmunologyMetabolic Disorders
Modalities: Cell therapy (therapeutic red blood cells)
Industry: Biotech

Beyond the preview

Go deeper on Scarlett Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scarlett Pharma.

Explore the full profile